Anti-HSV antibody

US9657088B2 · kind B2 · utility

Assignee

• Heidelberg ImmunoTherapeutics GmbH · DE

Inventors

• Michael Roggendorf · Essen, DE
• Anna-Maria Eis-Hübinger · Bornheim, DE
• Jürgen Krauss · Wilhelmsfeld, DE
• Karl Eduard Schneweis · Bonn, DE
• Michaela Arndt · Mannheim, DE
• Adalbert Krawczyk · Bad Hersfeld, DE
• Evelyn Exner · Nümbrecht, DE
• Martin P. Däumer · Kaiserslautern, DE

Key dates

• Filing date: Nov 17, 2014
• Grant date: May 23, 2017
• Expiry date: Jan 9, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising of an effective amount of the said antibody, an expression vector comprising of a nucleotide sequence which encodes the said antibody, a host cell comprising of the said nucleotide sequence, a hybridoma cell capable of producing the said antibody and the use of the said antibody as a drug, in particular to use for the manufacture of a drug for the prophylactical or therapeutical treatment of HSV-associated diseases in a subject; as defined in the claims.